Skip to Main Content

Advertisement

Skip Nav Destination

Not So Benign

A deepening understanding of the pathophysiologic underpinnings of immune thrombocytopenia has led to an expanding toolkit of therapeutic options. Read More

Issue Cover
Current Issue
Volume 21,
Issue 3,
May-June 2024

Featured Content

A Promising Strategy

The early adoption of CAR-T therapy represents a promising strategy in the evolving treatment landscape for multiple myeloma.

Lost Cause or Worth Fighting For?

A visiting professor recently marveled at our efforts in pushing fellows to acquire morphology skills, bemoaning that it was a lost cause.

Room To Grow

Treatment of pediatric chronic myeloid leukemia requires a balance of disease control and long-term toxicity.

Close Modal

or Create an Account

Close Modal
Close Modal